| Philip Willie Bankole Clarkson, MD | |
|
1945 State Route 33, Neptune, NJ 07753-4859 | |
| (732) 776-4483 | |
| (732) 776-4798 |
| Full Name | Philip Willie Bankole Clarkson |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 7 Years |
| Location | 1945 State Route 33, Neptune, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073923835 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bon Secours St Francis Medical Center | Midlothian, VA | Hospital |
| Bon Secours Richmond Community Hospital | Richmond, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vituity-virginia Hospitalists Pc | 6507245131 | 72 |
News Archive
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, today announced dosing the first patient in a Phase 2 trial of XmAb5871 in patients with IgG4-Related Disease (IgG4-RD).
The prospect of a non-invasive test of ovarian reserve is a little closer following results from a study showing that measurement of a fertility hormone can be accurately taken from a sample of human hair.
When parents hear the word "epilepsy," it typically triggers images of severe seizures – the ones that are easy to identify, involving a child falling, getting stiff and shaking all over. But the truth is, there are over 300,000 children and teens in the U.S. with epilepsy, and not all of them display such obvious signs of their medical condition.
Taiho Pharmaceutical Co., Ltd., and its parent company, Otsuka Holdings Co., Ltd., announced today that the European Commission has granted marketing authorization for Teysuno, a novel oral anti-cancer agent indicated for the treatment of adults with advanced gastric cancer when given in combination with cisplatin.
Congressional Republicans backed down on Monday from a demand that a payroll tax rollback be paid for with reductions in other programs, clearing the way for an extension of the tax cut for 160 million Americans through 2012. After months of partisan confrontation that left the tax break hanging in the balance, Republicans suddenly offered to extend the two-percentage-point cut while continuing to haggle over added unemployment benefits and a measure to prevent a drop in fees paid to doctors by Medicare.
› Verified 5 days ago
| Entity Name | Vituity-virginia Hospitalists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518611011 PECOS PAC ID: 6507245131 Enrollment ID: O20220628001137 |
News Archive
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, today announced dosing the first patient in a Phase 2 trial of XmAb5871 in patients with IgG4-Related Disease (IgG4-RD).
The prospect of a non-invasive test of ovarian reserve is a little closer following results from a study showing that measurement of a fertility hormone can be accurately taken from a sample of human hair.
When parents hear the word "epilepsy," it typically triggers images of severe seizures – the ones that are easy to identify, involving a child falling, getting stiff and shaking all over. But the truth is, there are over 300,000 children and teens in the U.S. with epilepsy, and not all of them display such obvious signs of their medical condition.
Taiho Pharmaceutical Co., Ltd., and its parent company, Otsuka Holdings Co., Ltd., announced today that the European Commission has granted marketing authorization for Teysuno, a novel oral anti-cancer agent indicated for the treatment of adults with advanced gastric cancer when given in combination with cisplatin.
Congressional Republicans backed down on Monday from a demand that a payroll tax rollback be paid for with reductions in other programs, clearing the way for an extension of the tax cut for 160 million Americans through 2012. After months of partisan confrontation that left the tax break hanging in the balance, Republicans suddenly offered to extend the two-percentage-point cut while continuing to haggle over added unemployment benefits and a measure to prevent a drop in fees paid to doctors by Medicare.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Philip Willie Bankole Clarkson, MD 1945 State Route 33, Neptune, NJ 07753-4859 Ph: (732) 776-4483 | Philip Willie Bankole Clarkson, MD 1945 State Route 33, Neptune, NJ 07753-4859 Ph: (732) 776-4483 |
News Archive
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, today announced dosing the first patient in a Phase 2 trial of XmAb5871 in patients with IgG4-Related Disease (IgG4-RD).
The prospect of a non-invasive test of ovarian reserve is a little closer following results from a study showing that measurement of a fertility hormone can be accurately taken from a sample of human hair.
When parents hear the word "epilepsy," it typically triggers images of severe seizures – the ones that are easy to identify, involving a child falling, getting stiff and shaking all over. But the truth is, there are over 300,000 children and teens in the U.S. with epilepsy, and not all of them display such obvious signs of their medical condition.
Taiho Pharmaceutical Co., Ltd., and its parent company, Otsuka Holdings Co., Ltd., announced today that the European Commission has granted marketing authorization for Teysuno, a novel oral anti-cancer agent indicated for the treatment of adults with advanced gastric cancer when given in combination with cisplatin.
Congressional Republicans backed down on Monday from a demand that a payroll tax rollback be paid for with reductions in other programs, clearing the way for an extension of the tax cut for 160 million Americans through 2012. After months of partisan confrontation that left the tax break hanging in the balance, Republicans suddenly offered to extend the two-percentage-point cut while continuing to haggle over added unemployment benefits and a measure to prevent a drop in fees paid to doctors by Medicare.
› Verified 5 days ago
Hani Naser, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1945 State Route 33, Neptune, NJ 07753 Phone: 732-776-4483 Fax: 732-776-4798 | |
Dr. Adam Chaim Kaplan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 19 Davis Ave Fl 6, Neptune, NJ 07753 Phone: 732-897-3990 Fax: 732-897-3997 | |
Jose Fune, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 19 Davis Ave Fl 6, Neptune, NJ 07753 Phone: 732-897-3995 Fax: 732-897-3997 | |
Dr. Daniel Mark Shenouda, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1945 State Route 33, Neptune, NJ 07753 Phone: 908-217-3023 Fax: 732-776-4798 | |
Dr. Kathleen King Casey, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 19 Davis Ave Fl 6, Neptune, NJ 07753 Phone: 732-897-3995 Fax: 732-897-3997 | |
Kelly West Fitzpatrick, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 19 Davis Ave Fl 2, Neptune, NJ 07753 Phone: 732-367-1535 Fax: 732-367-9514 |